Edition:
India

Catalent Inc (CTLT.N)

CTLT.N on New York Stock Exchange

43.29USD
1:34am IST
Change (% chg)

$0.43 (+1.00%)
Prev Close
$42.86
Open
$42.92
Day's High
$43.46
Day's Low
$42.91
Volume
188,187
Avg. Vol
335,440
52-wk High
$47.86
52-wk Low
$33.74

Chart for

About

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of... (more)

Overall

Beta: --
Market Cap(Mil.): $5,305.52
Shares Outstanding(Mil.): 125.46
Dividend: --
Yield (%): --

Financials

  CTLT.N Industry Sector
P/E (TTM): 48.96 30.93 32.76
EPS (TTM): 0.86 -- --
ROI: 3.86 15.07 14.61
ROE: 16.15 16.60 16.34

Catalent to buy Juniper Pharmaceuticals for $11.50 per share

U.S. drug contract manufacturer Catalent Inc said on Tuesday it will buy Juniper Pharmaceuticals Inc for $11.50 per share in cash.

03 Jul 2018

Catalent to buy Juniper Pharmaceuticals for $11.50 per share

July 3 U.S. drug contract manufacturer Catalent Inc said on Tuesday it will buy Juniper Pharmaceuticals Inc for $11.50 per share in cash.

03 Jul 2018

BRIEF-Catalent Announces Changes To Its Board Of Directors

* CATALENT - ANNOUNCED ADDITION OF 3 NEW MEMBERS TO BOARD AND RETIREMENT OF BOARD MEMBER JAMES QUELLA

20 Feb 2018

BRIEF-Catalent Posts Q2 Loss Per Share $0.16

* QTRLY ‍REVENUE OF $606.3 MILLION INCREASED 25% AS-REPORTED, OR 22 PCT IN CONSTANT CURRENCY FROM PRIOR-YEAR PERIOD​

05 Feb 2018

Earnings vs. Estimates